JAK2 and acquired polycythemia vera: Differential diagnoses at RA onset included undifferentiated connective tissue disease and reactive myeloproliferation secondary to inflammation, but persistent erythrocytosis and the JAK2 V617F mutation with polymerase chain reaction (PCR) confirmed PV.